新疆地区白念珠菌基因型分析及其体外药物敏感性研究

中国真菌学杂志　 2011, Vol. 6 　Issue (1): 10-14.

新疆地区白念珠菌基因型分析及其体外药物敏感性研究

帕丽达·阿布利孜¹, 哈木拉提·吾甫尔², Takashi Yaguchi³, Kayoko Takizawa³, 李若瑜⁴

1. 新疆医科大学第一附属医院皮肤科, 乌鲁木齐, 830053;
2. 新疆医科大学, 乌鲁木齐, 830053;
3. Medical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuoku, 260-8673 Chiba, Japan;
4. 北京大学第一医院皮肤性病科, 北京, 100034

收稿日期:2010-10-25 出版日期:2011-02-28 发布日期:2011-02-28
通讯作者: 李若瑜,E-mail:lry0660@gmail.com E-mail:lry0660@gmail.com
作者简介:帕丽达·阿布利孜,女,(维吾尔族),博士,副主任医师,硕士研究生导师.E-mail:palidaa@yahoo.com.cn
基金资助:
国家自然科学基金(30960351);新疆少数民族科技人才特殊培养计划科研项目(200823113);日本五峰生命科学基金(18405005)

Genotype analysis and antifungal susceptibility of Candida albicans in Xinjiang area

Paride Abliz¹, Halmurat Ghupur², Takashi Yaguchi³, Kayoko Takizawa³, LI Ruo-yu⁴

1. Department of Dermatology, The First Hospital of Xinjiang Medical University, Urumqi 830053;
2. Xinjiang Medical University, Urumqi 830053;
3. Medical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuoku, 260-8673 Chiba, Japan;
4. Department of Dermatology and Venereology, The First Hospital of Beijing University, 100034 Beijing

Received:2010-10-25 Online:2011-02-28 Published:2011-02-28

摘要/Abstract

摘要： 目的研究新疆地区汉族和维吾尔族患者来源的50株白念珠菌的基因型及其对两性霉素B、5-氟胞嘧啶、米卡芬净、伊曲康唑、氟康唑和咪康唑的体外敏感性。方法采用PCR法扩增白念珠菌rDNA 25S的Ⅰ类内含子包含区,根据扩增产物的大小判断基因型(A型为450 bp,B型为840 bp,C型为450 bp和840 bp)。采用CLSI M27-A液基微量稀释法测定50株白念珠菌对上述6种抗真菌药的体外敏感性。结果 50株菌分为3种基因型:A型30株,B型和C型各10株。所有菌株对两性霉素B、5-氟胞嘧啶、米卡芬净和咪康唑的MIC值较低,MIC范围依次为0.25～0.5μg/mL,0.125～0.5μg/mL,≤0.03μg/mL,0.25～8μg/mL;对伊曲康唑和氟康唑的MIC值较高,MIC范围分别为0.25～8μg/mL,0.5～64μg/mL。B型和C型对5-氟胞嘧啶的MIC值均为0.125μg/mL,对伊曲康唑和氟康唑的耐药率分别为84%、70%。不同族别来源的菌株基因型比较无显著差异(P>0.05),不同基因型菌株的抗真菌药物敏感性比较也无显著差异(P>0.05)。结论新疆地区白念珠菌分A,B,C三种基因型。汉族和维吾尔族患者来源的白念珠菌基因型及其对抗真菌药的敏感性以及基因型与种族间均无相关性。B型和C型对5-氟胞嘧啶高度敏感,所有菌株对伊曲康唑和氟康唑的耐药率较高。

关键词: 新疆地区, 白念珠菌, 基因型, 体外药敏

Abstract: Objective To analyze the genotypes of 50 isolates of Candida albicans from Han and Uyghur patients in Xinjiang area and to understand the in vitro antifungal susceptibilities of these isolates against amphotericin B,flucytosine,micafungin,itraconazole,fluconazole and miconazole.Methods The genotypes were identifed by the size of PCR amplicons amplifined from the group I intron contained region of 25S rDNA of C.albicans:genotype A(450 bp),genotype B(840 bp) and genotype C(450 bp and 840 bp).In vitro antifungal susceptibilities of 50 strains to 6 kind of antifungal agents were determined by CLSI M27-A microdilution method.Results Fifty strains were classified into three genotypes,including 30 strains of type A and 10 strains of type B and C,all these strains showed lower MIC to amphotericin B,flucytosine,micafungi,and miconazole(MIC range:0.25-0.5 μg/mL,0.125-0.25 μg/mL,≤0.03 μg/mL,and 0.25-8 μg/mL,respectively),and higher MIC to itraconazole and fluconazole(MIC range:0.25-8 μg/mL and 0.5-64 μg/mL,respectively).The MIC of the genotype B and C strains to flucytosine was 0.125 μg/mL.The resistant ratio of itraconazole and fluconazole were 84% and 70%,respectively.No statistical significance was found in the genotypes of the strains from different races(P>0.05) or different genotypic strains and antigungal susceptibilities(P>0.05).Conclusions C.albicans in Xinjiang area included 3 genotypes(A,B and C).There was no correlation between the genotype and antifungal susceptibilities of C.albicans strains from Han and Uyghur patients.Nither did genotype and race.All strains were resistant to itraconazole and flucytosine,but genotype B and C showed high susceptibilities to flucytosine.

Key words: Xinjiang area, Candida albicans, genotypes, in vitro antifungal susceptibilities

中图分类号:

R379.5

帕丽达·阿布利孜, 哈木拉提·吾甫尔, Takashi Yaguchi, Kayoko Takizawa, 李若瑜. 新疆地区白念珠菌基因型分析及其体外药物敏感性研究[J]. 中国真菌学杂志, 2011, 6(1): 10-14.

Paride Abliz, Halmurat Ghupur, Takashi Yaguchi, Kayoko Takizawa, LI Ruo-yu. Genotype analysis and antifungal susceptibility of Candida albicans in Xinjiang area[J]. Chinese Journal of Mycology, 2011, 6(1): 10-14.

参考文献

[1] McCullough M,Ross B,Reade P.Characterrization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus[J] .J Clin Microbiol,1995,33(3):696-700.
[2] Cetinkaya Z,Kiraz N./n vitro antifungal activities of phenotypic variation Candida albicans strains against fluconazole,itraconszole and voriconazole[J] .Jpn J Med Mycol,2005,46(3):197-201.
[3] Tamura M,Watanabe K,Mikami Y,et al.Molecular characterization of new clinical isolates of Candida albicans and C.dubliniensis in Japan:Analysis reveals a new genotype of C.albicans with group I intron[J] .J Clin Microbiol,2001,39(12):4309-4315.
[4] McCullough MJ,Clemons KV,Stevens DA.Molecular and phenotypic characterization of genotypic Candida albicans subgroups andcomparisonwithCandidadubliniensis and Candida stellatoidea[J] .J Clin Microbiol,1999,37(2):417-421.
[5] Kurtzman CP,Robnett CJ.Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5'end of the large-subunit (26S) ribosomal DNA gene[J] .J Clin Micmbiol,1997,35(5):1216-1223.
[6] National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility testing of yeasts.Approved standard M27-A[S] .Wayne,Pa.1997.
[7] 朱晓芳,汪清,章强强,等.念珠菌性外阴阴道炎患者身体不同部位白念珠菌基因型研究[J] .中华皮肤科杂志,2003,36(8):446-448.
[8] Kohno S.Kakeya H,Miyazaki Y.A new class of antifungal agent Candins[J] .Jpn J Chemo Ther,2002,50(12):840-847.
[9] Mercure S,Montplaisir S,Lemay G.Correlation between the presence of a self-splicing intmn in the 25S rDNA of Candida albicans and isolate susceptibility to 5-fluorocytosine[J] .Nucleic Acid Res,1993.21(25);6020-6027.

[1]	刘丹, 邢丽枝, 杨心茹, 罗伟, 何荣霞. 唑类药物治疗外阴阴道假丝酵母菌病研究进展[J]. 中国真菌学杂志, 2020, 15(5): 318-320.
[2]	马玉帛, 张逸, 黄晨, 王晓雯, 李若瑜. 自然杀伤细胞在真菌感染免疫的研究进展[J]. 中国真菌学杂志, 2020, 15(3): 175-178.
[3]	邱熙然, 陈思敏, 侯炜彤, 张玉, 郭诗雨, 姜远英, 安毛毛. 白念珠菌侵袭宿主毒力因子研究进展[J]. 中国真菌学杂志, 2020, 15(3): 183-188.
[4]	张静云, 彭靖雯, 王琼, 高盈, 陈万鑫, 沈永年, Li Dong-mei, 佘晓东, 刘维达. 表皮生长因子受体在阴道念珠菌病发病过程中的作用初探[J]. 中国真菌学杂志, 2020, 15(2): 65-71.
[5]	刘光荣, 翟春涛, 金敏蓉, 李成亮. 天然抗菌剂对5种致病菌的抑制作用研究[J]. 中国真菌学杂志, 2020, 15(2): 88-92.
[6]	谭静文, 徐红, 宋金凤, 高志琴, 杨虹, 杨连娟, 温海. 聚六亚甲基双胍体外抗真菌作用研究[J]. 中国真菌学杂志, 2020, 15(2): 93-96.
[7]	阚思玥, 蔡晴, 金云, 陈伟, 胡素泉, 杨连娟, 刘维达. 婴幼儿皮肤黏膜念珠菌病临床特点及其病原菌体外药敏分析[J]. 中国真菌学杂志, 2020, 15(2): 97-100.
[8]	张静云, 佘晓东, 刘维达. 白念珠菌糖代谢与毒力[J]. 中国真菌学杂志, 2020, 15(1): 61-64.
[9]	刘洁, 刘晓云, 于波, 胡小平. 85株皮肤癣菌感染的病原菌分析及标准化体外药物敏感性研究[J]. 中国真菌学杂志, 2019, 14(6): 351-356.
[10]	赵晓琴, 冯文莉. 转录因子在白念珠菌生物膜形成过程中的调控机制[J]. 中国真菌学杂志, 2019, 14(6): 381-384.
[11]	王钰婷, 王玉柱, 刘锦燕, 孟玲宁, 李卫华, 项明洁. 酵母相和菌丝相白念珠菌感染阴道上皮细胞免疫反应的比较[J]. 中国真菌学杂志, 2019, 14(4): 193-199.
[12]	蔡晴, 杨连娟, 高志琴, 任弘瑾, 杨虹, 谭静文. 罗米地辛对氟康唑体外抗白念珠菌影响的研究[J]. 中国真菌学杂志, 2019, 14(4): 200-203,216.
[13]	葛力瑜, 梁官钊, 刘维达. 抗黏膜白念珠菌感染的固有免疫研究进展[J]. 中国真菌学杂志, 2019, 14(4): 249-252.
[14]	姬名硕, 王晓东, 帕丽达·阿布利孜. NLRP3炎症小体在真菌感染中的作用机制研究进展[J]. 中国真菌学杂志, 2019, 14(4): 253-256.
[15]	施高翔, 姜晶晶, 汪云霞, 赵婷, 邵菁, 汪天明, 汪长中. 苦参-蛇床子药对提取物对白念珠菌VVC临床株的抑制作用研究[J]. 中国真菌学杂志, 2019, 14(3): 147-153.